|
PSMD10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.001450E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.344990E-03 |
| Normal-vs-Stage2 |
3.839900E-02 |
| Normal-vs-Stage3 |
2.12389999999507E-05 |
| Normal-vs-Stage4 |
2.60490000014713E-07 |
| Stage1-vs-Stage2 |
6.617600E-01 |
| Stage1-vs-Stage3 |
3.694400E-02 |
| Stage1-vs-Stage4 |
2.017200E-03 |
| Stage2-vs-Stage3 |
7.906300E-02 |
| Stage2-vs-Stage4 |
5.859200E-03 |
| Stage3-vs-Stage4 |
1.754830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37579999999848E-05 |
| Normal-vs-AfricanAmerican |
2.402200E-01 |
| Normal-vs-Asian |
1.781890E-03 |
| Caucasian-vs-AfricanAmerican |
1.102380E-01 |
| Caucasian-vs-Asian |
7.320600E-01 |
| AfricanAmerican-vs-Asian |
2.256200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.20700000000252E-05 |
| Normal-vs-Female |
3.350200E-04 |
| Male-vs-Female |
2.740000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.358900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.000100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.55140000000143E-05 |
| Normal-vs-Age(81-100Yrs) |
7.208100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.160240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.748100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.371200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.343200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.787200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.028200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.424600E-03 |
| Classical-VS-Follicular |
9.678400E-01 |
| Classical-VS-Other |
8.725000E-01 |
| Classical-VS-Normal |
7.373800E-04 |
| Tall-VS-Follicular |
3.186300E-02 |
| Tall-VS-Other |
2.991000E-01 |
| Tall-VS-Normal |
4.50699999998694E-06 |
| Follicular-VS-Other |
8.806400E-01 |
| Follicular-VS-Normal |
8.663400E-03 |
| Other-VS-Normal |
1.383440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.172500E-04 |
| Normal-vs-N1 |
2.36519999999851E-05 |
| N0-vs-N1 |
6.233900E-02 |
|
|
